Hy's law: predicting serious hepatotoxicity

Pharmacoepidemiol Drug Saf. 2006 Apr;15(4):241-3. doi: 10.1002/pds.1211.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Alanine Transaminase / blood
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anticoagulants / adverse effects*
  • Azetidines / adverse effects
  • Benzophenones / adverse effects
  • Benzylamines / adverse effects
  • Bilirubin / blood
  • Biomarkers / blood
  • Bromobenzenes / adverse effects
  • Chemical and Drug Induced Liver Injury / blood
  • Chemical and Drug Induced Liver Injury / enzymology
  • Chemical and Drug Induced Liver Injury / etiology*
  • Chromans / adverse effects
  • Drug Approval
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Liver / drug effects*
  • Liver / enzymology
  • Predictive Value of Tests
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Thiazolidinediones / adverse effects
  • Troglitazone
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Anticoagulants
  • Azetidines
  • Benzophenones
  • Benzylamines
  • Biomarkers
  • Bromobenzenes
  • Chromans
  • Hypoglycemic Agents
  • Thiazolidinediones
  • ximelagatran
  • bromfenac
  • Alanine Transaminase
  • Troglitazone
  • Bilirubin